The occurrence of LPD in RA patient with receiving immunosuppressive therapy is recognized as the “Immunodeficiency-associated LPDs” by the World Health Organization (WHO) and a possible link between TNF-α inhibitors treatment and increased risk of lymphoma has been suggested (Das et al. 2004). This evidence concerns the gene TNF and rheumatoid arthritis.